Zobrazeno 1 - 10 of 26 pro vyhledávání: '"Charles Vesteghem"'
1
Akademický článek
Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
Autor: Mia Sommer, Lene Kongsgaard Nielsen, Lars Børty Nielsen, Rasmus Froberg Brøndum, Marlene Maria Nielsen, Anne Stoffersen Rytter, Charles Vesteghem, Marianne Tang Severinsen, Tarec Christoffer El-Galaly, Martin Bøgsted, Mette Grønkjær, Lone Jørgensen
Publikováno v: Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background Patients with hematological cancer who experience relapse or progressive disease often face yet another line of treatment and continued mortality risk that could increase their physical and emotional trauma and worsen their health
Externí odkaz: https://doaj.org/article/ce184fa0ab4249ae8ac6685488070625
Zobrazit plný text záznamu
2
Akademický článek
Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma.
Autor: Mette Marcussen, Mads Sønderkær, Julie Støve Bødker, Maria Andersen, Søren Nielsen, Charles Vesteghem, Ilse Christiansen, Olav Jonas Bergmann, Martin Bøgsted, Karen Dybkær, Mogens Vyberg, Hans Erik Johnsen
Publikováno v: PLoS ONE, Vol 13, Iss 1, p e0190709 (2018)
BACKGROUND:Radiation-therapy (RT) induces mucositis, a clinically challenging condition with limited prophylactic interventions and no predictive tests. In this pilot study, we applied global gene-expression analysis on serial human oral mucosa tissu
Externí odkaz: https://doaj.org/article/a786d2c7443c4c56867a495a53ccd492
Zobrazit plný text záznamu
3
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy
Autor: Lars Børty, Rasmus F. Brøndum, Heidi S. Christensen, Charles Vesteghem, Marianne Severinsen, Søren P. Johnsen, Lars H. Ehlers, Ursula Falkmer, Laurids Ø. Poulsen, Martin Bøgsted
Publikováno v: Børty, L, Brøndum, R F, Christensen, H S, Vesteghem, C, Severinsen, M, Johnsen, S P, Ehlers, L H, Falkmer, U, Poulsen, L Ø & Bøgsted, M 2023, ' Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy ', The European Journal of Health Economics, vol. 24, no. 6, pp. 853–865 . https://doi.org/10.1007/s10198-022-01515-0
Børty, L, Brøndum, R F, Christensen, H S, Vesteghem, C, Severinsen, M, Johnsen, S P, Ehlers, L H, Falkmer, U, Poulsen, L Ø & Bøgsted, M 2022, ' Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy ', The European Journal of Health Economics . https://doi.org/10.1007/s10198-022-01515-0
Expenditures on medicine for systemic anti-cancer therapy (SACT) have seen large increases in recent years. The characterization of patients with high SACT costs is crucial to identify cost-driving factors, but little is known about the distribution
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda169bc56cf99f52107cf682a56a138
https://vbn.aau.dk/da/publications/ededcc58-8609-4d99-a9d9-ad2915f51728
Zobrazit plný text záznamu
4
High Validity of the Danish National Patient Registry for Systemic Anticancer Treatment Registration from 2009 to 2019
Autor: Anton Pottegård, Laurids Østergaard Poulsen, Martin Bøgsted, Ursula Falkmer, Charles Vesteghem, Rasmus Froberg Brøndum
Publikováno v: Vesteghem, C, Brøndum, R F, Falkmer, U G, Pottegård, A, Poulsen, L Ø & Bøgsted, M 2021, ' High validity of the danish national patient registry for systemic anticancer treatment registration from 2009 to 2019 ', Clinical Epidemiology, vol. 13, pp. 1085-1094 . https://doi.org/10.2147/CLEP.S332776
Clinical Epidemiology
Charles Vesteghem,1– 3 Rasmus Froberg Brøndum,1– 3 Ursula G Falkmer,1,3,4 Anton Pottegård,5 Laurids Østergaard Poulsen,1,3,4 Martin Bøgsted1– 3 1Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; 2Depart
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5332f97335e1d0d321adedea6cfdc0
https://doi.org/10.2147/clep.s332776
Zobrazit plný text záznamu
5
Dynamic Risk Prediction of 30-Day Mortality in Patients With Advanced Lung Cancer:Comparing Five Machine Learning Approaches
Autor: Charles Vesteghem, Weronika M. Szejniuk, Rasmus F. Brøndum, Ursula G. Falkmer, Chloé-Agathe Azencott, Martin Bøgsted
Publikováno v: Vesteghem, C, Szejniuk, W M, Brøndum, R F, Falkmer, U G, Azencott, C-A & Bøgsted, M 2022, ' Dynamic Risk Prediction of 30-Day Mortality in Patients With Advanced Lung Cancer : Comparing Five Machine Learning Approaches ', JCO Clinical Cancer Informatics, vol. 6, e2200054, pp. e2200054 . https://doi.org/10.1200/CCI.22.00054
Vesteghem, C, Szejniuk, W M, Brøndum, R F, Falkmer, U G, Azencott, C-A & Bøgsted, M 2022, ' Dynamic Risk Prediction of 30-Day Mortality in Patients With Advanced Lung Cancer : Comparing Five Machine Learning Approaches ', JCO Clinical Cancer Informatics, vol. 6, e2200054 . https://doi.org/10.1200/CCI.22.00054
PURPOSE Administering systemic anticancer treatment (SACT) to patients near death can negatively affect their health-related quality of life. Late SACT administrations should be avoided in these cases. Machine learning techniques could be used to bui
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4df51f6b4e7a520288d8a58c9f0dbccf
https://vbn.aau.dk/da/publications/193bedf7-e3a8-4a28-852e-8e8ad6c68cc0
Zobrazit plný text záznamu
7
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy
Autor: Lars, Børty, Rasmus F, Brøndum, Heidi S, Christensen, Charles, Vesteghem, Marianne, Severinsen, Søren P, Johnsen, Lars H, Ehlers, Ursula, Falkmer, Laurids Ø, Poulsen, Martin, Bøgsted
Publikováno v: The European journal of health economics : HEPAC : health economics in prevention and care.
Expenditures on medicine for systemic anti-cancer therapy (SACT) have seen large increases in recent years. The characterization of patients with high SACT costs is crucial to identify cost-driving factors, but little is known about the distribution
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::eb8b477db58f4b76fb8756ebe5977c30
https://pubmed.ncbi.nlm.nih.gov/36028607
Zobrazit plný text záznamu
8
Patient-reported outcomes in patients with hematological relapse or progressive disease:a longitudinal observational study
Autor: Lone Jørgensen, Lars Børty Nielsen, Tarec Christoffer El-Galaly, Rasmus Froberg Brøndum, Charles Vesteghem, Martin Bøgsted, Anne Stoffersen Rytter, Marlene Maria Nielsen, Mette Grønkjær, Mia Sommer, Marianne Tang Severinsen, Lene Kongsgaard Nielsen
Publikováno v: Sommer, M, Nielsen, L K, Nielsen, L B, Brøndum, R F, Nielsen, M M, Rytter, A S, Vesteghem, C, Severinsen, M T, El-Galaly, T C, Bøgsted, M, Grønkjær, M & Jørgensen, L 2021, ' Patient-reported outcomes in patients with hematological relapse or progressive disease : a longitudinal observational study ', Health and Quality of Life Outcomes, vol. 19, 251 . https://doi.org/10.1186/s12955-021-01887-6
Sommer, M, Nielsen, L K, Nielsen, L B, Brøndum, R F, Nielsen, M M, Rytter, A S, Vesteghem, C, Severinsen, M T, El-Galaly, T C, Bøgsted, M, Grønkjær, M & Jørgensen, L 2021, ' Patient-reported outcomes in patients with hematological relapse or progressive disease : a longitudinal observational study ', Health and Quality of Life Outcomes, vol. 19, no. 1, 251 . https://doi.org/10.1186/s12955-021-01887-6
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Health and Quality of Life Outcomes
Sommer, M, Nielsen, L K, Nielsen, L B, Brøndum, R F, Nielsen, M M, Rytter, A S, Vesteghem, C, Severinsen, M T, El-Galaly, T C, Bøgsted, M, Grønkjær, M & Jørgensen, L 2021, ' Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study ', Health and Quality of Life Outcomes, vol. 19, no. 251, 251 . https://doi.org/10.1186/s12955-021-01887-6
Background Patients with hematological cancer who experience relapse or progressive disease often face yet another line of treatment and continued mortality risk that could increase their physical and emotional trauma and worsen their health-related
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0adb887741afc027c1efe01247336d4
https://findresearcher.sdu.dk:8443/ws/files/194418550/s12955_021_01887_6.pdf
Zobrazit plný text záznamu
9
Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system
Autor: Lars Holger Ehlers, Anne Stoffersen Rytter, Henrik Gregersen, Marlene Maria Nielsen, Martin Bøgsted, Karen Dybkær, Anne Stidsholt Roug, Marianne Tang Severinsen, Anne Sig Vestergaard, Lars Børty, Paw Jensen, Rasmus Froberg Brøndum, Tarec Christoffer El-Galaly, Charles Vesteghem
Publikováno v: Brøndum, R F, Vestergaard, A S, Børty, L, Vesteghem, C, Rytter, A S, Nielsen, M M, Severinsen, M T, Jensen, P, Gregersen, H, El-Galaly, T C, Dybkær, K, Ehlers, L H, Bøgsted, M & Roug, A S 2021, ' Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system ', Future Oncology, vol. 17, no. 25, pp. 3331-3341 . https://doi.org/10.2217/fon-2021-0189
Aim: To estimate current real-world costs of drugs and supportive care for the treatment of multiple myeloma in a tax-based health system. Methods: Forty-one patients were included from a personalized medicine study (2016–2019). Detailed informatio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::821e342c47a8b4267239e19094cb9f46
https://pubmed.ncbi.nlm.nih.gov/34156281
Zobrazit plný text záznamu
10
Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark
Autor: Alexander Schmitz, Marianne Tang Severinsen, Anne Stidsholt Roug, Mads Sønderkær, Julie Støve Bødker, Martin Bøgsted, Tarec Christoffer El-Galaly, Rasmus Froberg Brøndum, Anne Stoffersen Rytter, Charles Vesteghem, Karen Dybkær, Lykke Christina Grubach, Jakob Madsen, Inge Søkilde Pedersen, Marlene Maria Nielsen, Paw Jensen, Mia Sommer
Publikováno v: Cancers, Vol 12, Iss 2, p 312 (2020)
Vesteghem, C, Sommer, M, Rytter, A S, Nielsen, M M, Roug, A S, El-Galaly, T C, Dybkaer, K & Bøgsted, M 2020, ' Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark ', Cancers, vol. 12, no. 2 . https://doi.org/10.3390/cancers12020312
Bødker, J S, Sønderkær, M, Vesteghem, C, Schmitz, A, Brøndum, R F, Sommer, M, Rytter, A S, Nielsen, M M, Madsen, J, Jensen, P, Pedersen, I S, Grubach, L, Severinsen, M T, Roug, A S, El-Galaly, T C, Dybkær, K & Bøgsted, M 2020, ' Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark ', Cancers, vol. 12, no. 2, 312 . https://doi.org/10.3390/cancers12020312
Cancers
Volume 12
Issue 2
Within recent years, many precision cancer medicine initiatives have been developed. Most of these have focused on solid cancers, while the potential of precision medicine for patients with hematological malignancies, especially in the relapse situat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9e8c4e20fa7b1244a8cca64892cf27
https://www.mdpi.com/2072-6694/12/2/312
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje